Cargando…
Levetiracetam Liver Injury: A Benign Antiepileptic Agent?
Levetiracetam is a commonly prescribed antiepileptic agent and has rarely been linked to hepatotoxicity. This case describes a patient with drug-induced autoimmune hepatitis secondary to levetiracetam.
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019274/ https://www.ncbi.nlm.nih.gov/pubmed/36936131 http://dx.doi.org/10.14309/crj.0000000000001003 |
_version_ | 1784907994285211648 |
---|---|
author | Hegazy, Yassmin Axley, Page Lee, Goo Gray, Meagan |
author_facet | Hegazy, Yassmin Axley, Page Lee, Goo Gray, Meagan |
author_sort | Hegazy, Yassmin |
collection | PubMed |
description | Levetiracetam is a commonly prescribed antiepileptic agent and has rarely been linked to hepatotoxicity. This case describes a patient with drug-induced autoimmune hepatitis secondary to levetiracetam. |
format | Online Article Text |
id | pubmed-10019274 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer |
record_format | MEDLINE/PubMed |
spelling | pubmed-100192742023-03-17 Levetiracetam Liver Injury: A Benign Antiepileptic Agent? Hegazy, Yassmin Axley, Page Lee, Goo Gray, Meagan ACG Case Rep J Case Report Levetiracetam is a commonly prescribed antiepileptic agent and has rarely been linked to hepatotoxicity. This case describes a patient with drug-induced autoimmune hepatitis secondary to levetiracetam. Wolters Kluwer 2023-03-16 /pmc/articles/PMC10019274/ /pubmed/36936131 http://dx.doi.org/10.14309/crj.0000000000001003 Text en © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Hegazy, Yassmin Axley, Page Lee, Goo Gray, Meagan Levetiracetam Liver Injury: A Benign Antiepileptic Agent? |
title | Levetiracetam Liver Injury: A Benign Antiepileptic Agent? |
title_full | Levetiracetam Liver Injury: A Benign Antiepileptic Agent? |
title_fullStr | Levetiracetam Liver Injury: A Benign Antiepileptic Agent? |
title_full_unstemmed | Levetiracetam Liver Injury: A Benign Antiepileptic Agent? |
title_short | Levetiracetam Liver Injury: A Benign Antiepileptic Agent? |
title_sort | levetiracetam liver injury: a benign antiepileptic agent? |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019274/ https://www.ncbi.nlm.nih.gov/pubmed/36936131 http://dx.doi.org/10.14309/crj.0000000000001003 |
work_keys_str_mv | AT hegazyyassmin levetiracetamliverinjuryabenignantiepilepticagent AT axleypage levetiracetamliverinjuryabenignantiepilepticagent AT leegoo levetiracetamliverinjuryabenignantiepilepticagent AT graymeagan levetiracetamliverinjuryabenignantiepilepticagent |